Company / FCF Margin
REGENXBIO Inc. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-74.2%
FY2025
5-year range
-339.0% / -74.2%
FY2021-FY2025
Trend
+64.8%
vs FY2024
Sector context
#85 of 133
Health Care
What the data says
At -74.2%, REGENXBIO Inc.'s fcf margin ranks #85 of 133 in the Health Care sector. FCF Margin has fluctuated over the past 10 years, ranging from -14319.1% in FY2017 to 41.8% in FY2020.
Based on SEC 10-K filings.
-74.2% in FY2025 with a 5-year CAGR of -116.0%.
Improved from -253.1% to -74.2% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +137.2pp
- 5-Year Change
- -116.0pp
- 10-Year Change
- -
Sector benchmark
#85 of 133 in Health CareTop 64% of 133This company -74.2% Sector average -632.8%
▼
+88.3% above sector average
Key checks
Key Insights
- In FY2025, fcf margin increased 64.8% year-over-year.
- Currently 558.7pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2020.
- Lowest fcf margin in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -74.2% | +64.8% |
| FY2024 | -210.7% | +16.7% |
| FY2023 | -253.1% | -19.8% |
| FY2022 | -211.3% | +37.7% |
| FY2021 | -339.0% | -910.5% |
| FY2020 | 41.8% | +106.7% |
| FY2019 | -626.9% | -1599.0% |
| FY2018 | 41.8% | +100.3% |
| FY2017 | -14319.1% | -29900.3% |
| FY2016 | -47.7% | +17.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026